Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Egerton

Showing results (561-570 of 623) with videos related to

Pageof 63
Sort By:
Journal of Medical Internet Research|December 4, 2019
Exploring the Characteristics and Preferences for Online Support Groups: Mixed Method StudyMelanie Louise Plinsinga, Manuela Besomi, Liam Maclachlan, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Molecular Genetics and Metabolism|March 8, 2024
Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatmentTeresa H Y Wu, Heather A Brown, Heather J Church, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Toxicon: X|July 14, 2023
Co-occurrence of marine and freshwater phycotoxins in oysters, and analysis of possible predictors for managementSarah K D Pease, Todd A Egerton, Kimberly S Reece, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Nature Communications|May 23, 2019
Pheomelanin pigment remnants mapped in fossils of an extinct mammalPhillip L Manning, Nicholas P Edwards, Uwe Bergmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 2022
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaborationAlice Egerton, Kira Griffiths, Cecila Casetta, et al.
Pageof 63

Showing results (561-570 of 623) with videos related to

Sort By:
Pageof 63
Journal of Medical Internet Research|December 4, 2019
Exploring the Characteristics and Preferences for Online Support Groups: Mixed Method StudyMelanie Louise Plinsinga, Manuela Besomi, Liam Maclachlan, et al.
Biological Psychiatry|February 4, 2021
Relationship Between Serum NMDA Receptor Antibodies and Response to Antipsychotic Treatment in First-Episode PsychosisThomas A Pollak, Angela Vincent, Conrad Iyegbe, et al.
Molecular Genetics and Metabolism|March 8, 2024
Improving newborn screening test performance for metachromatic leukodystrophy: Recommendation from a pre-pilot study that identified a late-infantile case for treatmentTeresa H Y Wu, Heather A Brown, Heather J Church, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 12, 2014
Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosisAlice Egerton, James M Stone, Christopher A Chaddock, et al.
Schizophrenia Bulletin|January 5, 2021
Changes in Brain Glutamate on Switching to Clozapine in Treatment-Resistant SchizophreniaGrant McQueen, Kyra-Verena Sendt, Amy Gillespie, et al.
Toxicon: X|July 14, 2023
Co-occurrence of marine and freshwater phycotoxins in oysters, and analysis of possible predictors for managementSarah K D Pease, Todd A Egerton, Kimberly S Reece, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.
Schizophrenia (Heidelberg, Germany)|March 3, 2022
Subcortical volume reduction and cortical thinning 3 months after switching to clozapine in treatment resistant schizophreniaFanni Krajner, Laila Hadaya, Grant McQueen, et al.
Nature Communications|May 23, 2019
Pheomelanin pigment remnants mapped in fossils of an extinct mammalPhillip L Manning, Nicholas P Edwards, Uwe Bergmann, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 1, 2022
Anterior cingulate glutamate metabolites as a predictor of antipsychotic response in first episode psychosis: data from the STRATA collaborationAlice Egerton, Kira Griffiths, Cecila Casetta, et al.
Pageof 63